To investigate whether advanced sporadic bladder tumors include potentially undiagnosed Lynch syndrome patients, we performed IHC for MLH1, MSH2, and MSH6 in a population‐based cohort (n = 383) (Sjödahl et al., 2017). The gene discussed is MLH1; the disease is Lynch syndrome.